Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) Following Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplants (HCT) Treated with Tabelecleucel on an Expanded Access Program

Susan Prockop, MD, Ran Reshef, MDMSc, Donald E. Tsai, MD PhD, Nancy Bunin, MD, Rolla Abu-Arja, MD, Kris Michael Mahadeo, MD, Wen-Kai Weng, MD PhD, Koen Van Besien, MD PhD, David Loeb, MD PhD, Sunita Dwivedy Nasta, MD, Eneida R. Nemecek, MDMBA,MSc, Minoti Hiremath, MBBS, PhD, Susan Yue, MD, Yan Sun, PhD, Willis Navarro, MD, Sarah Nikiforow, MD PhD

Blood (2019) 134 (Supplement_1): 4071.

https://doi.org/10.1182/blood-2019-124904

Published: 2019

Journal Articles

A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in Combination with Daratumumab As a Salvage Regimen for Multiple Myeloma

Nina D. Shah, MD, Cameron J. Turtle, MBBS, PhD, Andrew J. Cowan, MD, Julio C. Chavez, MD, Lihua E Budde, MD PhD, Mario Q. Marcondes, MD PhD, Zachary Lee, PharmD, Wei Lin, MD, Jonathan Zalevsky, Mary Tagliaferri, MD, Krina K. Patel, MDMSc

Blood (2019) 134 (Supplement_1): 4459.

https://doi.org/10.1182/blood-2019-122494

Published: 2019

Journal Articles

FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma

Ryan Bjordahl, PhD, Svetlana Gaidarova, MS, Jode P Goodridge, PhD, Sajid Mahmood, PhD, Greg Bonello, PhD, Megan Robinson, Chelsea Ruller, Mochtar Pribadi, PhD, Tom Lee, PhD, Ramzey Abujarour, PhD, Jason Dinella, PhD, Janel Huffman, MS, Hui-yi Chu, PhD, Uta Hopken, Armin Rehm, Bahram Valamehr, PhD

Blood (2019) 134 (Supplement_1): 3214.

https://doi.org/10.1182/blood-2019-131373

Published: 2019

Journal Articles

Adoptively Transferred Donor-Derived Cytokine Induced Memory-like NK Cells Persist and Induce Remission in Pediatric Patient with Relapsed Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

Jeffrey J. Bednarski, MD PhD, Clare Zimmerman, MD, Amanda F Cashen, MD, Sweta Desai, Mark Foster, Tim Schappe, BS, Ethan McClain, Michelle Becker-Hapak, BS, Melissa M Berrien-Elliott, PhD, Todd A Fehniger, MD PhD

Blood (2019) 134 (Supplement_1): 3307.

https://doi.org/10.1182/blood-2019-126982

Published: 2019

Journal Articles

Direct Comparison of in-Vitro Growth of Primary Human Acute Myeloid Leukemia (AML) Cells in Stromal and Stromal-Free Conditions

Jing Chen, MD, Glorymar Ibanez-Sanchez, Paul Calder, Mark G. Frattini, MD PhD

Blood (2018) 132 (Supplement 1): 5096.

https://doi.org/10.1182/blood-2018-99-116978

Published: 2018

Journal Articles

Off-the-Shelf Natural Killer Cells with Multi-Functional Engineering Using a Novel Anti-CD19 Chimeric Antigen Receptor Combined with Stabilized CD16 and IL15 Expression to Enhance Directed Anti-Tumor Activity

Dan S Kaufman, MD PhD, Ryan Bjordahl, PhD, Huang Zhu, PhD, Robert Blum, Andres Bahena, Sajid Mahmood, PhD, Greg Bonello, PhD, Tom Lee, PhD, Bruce Walcheck, PhD, Frank Cichocki, PhD, Jeffrey S. Miller, MD, Bahram Valamehr, PhD

Blood (2018) 132 (Supplement 1): 4541.

https://doi.org/10.1182/blood-2018-99-113701

Published: 2018

Journal Articles

A Novel TGF-β 2 /Interleukin Receptor Signal Conversion Platform That Protects CAR/TCR T Cells from TGF-β 2 -Mediated Immune Suppression and Induces T Cell Supportive Signaling Networks

Benjamin Boyerinas, Sara M. Miller, Ryan C. Murray, John W. Evans, Geoffrey B. Parsons, Katherine J. Seidl, Kevin M. Friedman, Richard A. Morgan, PhD

Blood (2017) 130 (Supplement 1): 1911.

https://doi.org/10.1182/blood.V130.Suppl_1.1911.1911

Published: 2017

Journal Articles

Stroma-Based Versus Stroma-Free Long-Term Survival and Proliferation of Primary Acute Myeloid Leukemia (AML) Cells

Jing Chen, MD, Glorymar Ibanez-Sanchez, Paul Calder, Mark G. Frattini, MD PhD

Blood (2017) 130 (Supplement 1): 5569.

https://doi.org/10.1182/blood.V130.Suppl_1.5569.5569

Published: 2017

Journal Articles

The IL15 Superagonist Complex ALT-803 Potently Enhances the Proliferative Capacity and Activity of in Vitro Expanded Natural Killer Cells

Tarun K. Garg, PhD, Katie Stone, BS, Amy Greenway, Carolina D. Schinke, MD, Sharmilan Thanendrarajan, MD, Maurizio Zangari, MD, Joshua Epstein, DSc, Brian A Walker, PhD, Hing C Wong, PhD, Emily K Jeng, Niraj Shrestha, Faith E Davies, MD, Gareth J. Morgan, MD PhD, Frits van Rhee, MD PhD

Blood (2017) 130 (Supplement 1): 5452.

https://doi.org/10.1182/blood.V130.Suppl_1.5452.5452

Published: 2017

Journal Articles

Inhibition of the Histone Chaperone, FACT (Facilitates Chromatin Transcription) By the Novel Small Molecule CBL0137 (Curaxin) Shows Promising Efficacy in Pre-Clinical Models of Acute Myeloid Leukemia

Scott Portwood, MS, Eunice S. Wang, MD, Alfiya Safina, PhD, Katerina Gurova, MDPhD

Blood (2017) 130 (Supplement 1): 1372.

https://doi.org/10.1182/blood.V130.Suppl_1.1372.1372

Published: 2017

Journal Articles

Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy

Ryan Bjordahl, PhD, Raedun Clarke, PhD, Svetlana Gaidarova, Matthieu Bauer, PhD, Jeff Sasaki, Brian Groff, Tom Lee, PhD, Weijie Lan, PhD, Ramzey Abujarour, PhD, Greg Bonello, PhD, Megan Robinson, Ian Hardy, PhD, Daniel Shoemaker, PhD, Bahram Valamehr, PhD

Blood (2017) 130 (Supplement 1): 3187.

https://doi.org/10.1182/blood.V130.Suppl_1.3187.3187

Published: 2017

Journal Articles

Spatiotemporal Mapping of Erythroid, Stromal, and Osteogenic Niche Formation to Support Physiologic Red Cell Production in a Three-Dimensional Hollow Fibre Perfusion Bioreactor

Mark C. Allenby, MSc, Asma Tahlawi, MSc, Ruth Misener, PhD, Susana Brito dos Santos, MSc, Athanasios Mantalaris, PhD, Nicki Panoskaltsis, MD PhD

Blood (2016) 128 (22): 3885.

https://doi.org/10.1182/blood.V128.22.3885.3885

Published: 2016

Journal Articles

Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function

Tarun K. Garg, PhD, Jessica I Gann, Priyangi A Malaviarachchi, BS, Kate Stone, BS, Veronica Macleod, Amy D Greenway, Nisreen S Akel, Ricky D Edmondson, PhD, Faith E Davies, MD, Joshua Epstein, DSc, Gareth J Morgan, MD PhD, Frits van Rhee, MD PhD

Blood (2016) 128 (22): 2066.

https://doi.org/10.1182/blood.V128.22.2066.2066

Published: 2016

Journal Articles

The IL-15 Super-Agonist ALT-803 Promotes Superior Activation and Cytotoxicity of Ex Vivo Expanded NK Cells Against AML

Folashade Otegbeye, MD MPH, Nathan Mackowski, BA, Evelyn Ojo, BS, Marcos De Lima, MD, David N. Wald, MDPhD

Blood (2015) 126 (23): 3090.

https://doi.org/10.1182/blood.V126.23.3090.3090

Published: 2015

Journal Articles

The Tumor Suppressors, MS4A3 and G0S2, Are Downregulated in CML Cells with BCR-ABL1 Kinase-Independent Resistance

Anna M. Eiring, PhD, Anupriya Agarwal, Jamshid S. Khorashad, MD PhD, Clinton C. Mason, PhD, David J. Anderson, MBA, Fan Yu, MD, PhD, Hannah M. Redwine, Kevin C. Gantz, Kimberly R. Reynolds, M.S., Shannon K. McWeeney, Brian J. Druker, Thomas O'Hare, Michael W. Deininger

Blood (2014) 124 (21): 1786.

https://doi.org/10.1182/blood.V124.21.1786.1786

Published: 2014

Journal Articles

BCR-ABL1 Molecular Remission After 90 y-Epratuzumab Tetraxetan Radioimmunotherapy In CD22 + Ph + B-ALL: A Potential New Treatment Paradigm

Patrice Chevallier, MD, PhD, Caroline bodet-Milin, MD, Nelly Robillard, Thomas Eugene, MD, Audrey Ménard, Claire Le Houerou, Thierry Guillaume, MD, Jacques Delaunay, MD, Martine Escoffre-Barbe, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Françoise kraeber-Bodere, MD

Blood (2013) 122 (21): 3910.

https://doi.org/10.1182/blood.V122.21.3910.3910

Published: 2013

Journal Articles

Dose Escalation of Azacitidine in Patients Failing Standard or Investigational Combinations of the Agent in the Myelodysplastiic Syndrome or Evolved AML

Lewis R. Silverman, MD, Shyamala C. Navada, MD, Rosalie Odchimar-Reissig, RN, Maria Michalak, PA-C, Erin P Demakos, RN, CCRN, James F Holland, MD

Blood (2012) 120 (21): 4932.

https://doi.org/10.1182/blood.V120.21.4932.4932

Published: 2012

Journal Articles

Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial.

Ranjana H Advani, MD, Richard T Hoppe, MD, David M. Baer, MD, Joseph Mason, M.D, Saul A Rosenberg, M.D, Sandra J Horning, MD

Blood (2009) 114 (22): 1670.

https://doi.org/10.1182/blood.V114.22.1670.1670

Published: 2009

Journal Articles

IL-7 as a Membrane-Bound Molecule for the Costimulation of Tumor-Specific T Cells.

Lenka V. Hurton, MS, Harjeet Singh, PhD, Simon Olivares, BS, Sonny O. Ang, PhD, Susan Staba Kelly, MD, Partow Kebriaei, MD, Dean A. Lee, MD, PhD, Richard E. Champlin, MD, Laurence J.N. Cooper, MD

Blood (2009) 114 (22): 3035.

https://doi.org/10.1182/blood.V114.22.3035.3035

Published: 2009

Journal Articles

DNMT3b’s Role in Hematopoietic Stem Cell Self-Renewal.

Matthew J Boyer, Feng Xu, MD, Hui Yu, MD, PhD, Tao Cheng, MD

Blood (2008) 112 (11): 1406.

https://doi.org/10.1182/blood.V112.11.1406.1406

Published: 2008

NARROW

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) Following Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplants (HCT) Treated with Tabelecleucel on an Expanded Access Program

A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in Combination with Daratumumab As a Salvage Regimen for Multiple Myeloma

FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma

Adoptively Transferred Donor-Derived Cytokine Induced Memory-like NK Cells Persist and Induce Remission in Pediatric Patient with Relapsed Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

Direct Comparison of in-Vitro Growth of Primary Human Acute Myeloid Leukemia (AML) Cells in Stromal and Stromal-Free Conditions

Off-the-Shelf Natural Killer Cells with Multi-Functional Engineering Using a Novel Anti-CD19 Chimeric Antigen Receptor Combined with Stabilized CD16 and IL15 Expression to Enhance Directed Anti-Tumor Activity

A Novel TGF-β 2 /Interleukin Receptor Signal Conversion Platform That Protects CAR/TCR T Cells from TGF-β 2 -Mediated Immune Suppression and Induces T Cell Supportive Signaling Networks

Stroma-Based Versus Stroma-Free Long-Term Survival and Proliferation of Primary Acute Myeloid Leukemia (AML) Cells

The IL15 Superagonist Complex ALT-803 Potently Enhances the Proliferative Capacity and Activity of in Vitro Expanded Natural Killer Cells

Inhibition of the Histone Chaperone, FACT (Facilitates Chromatin Transcription) By the Novel Small Molecule CBL0137 (Curaxin) Shows Promising Efficacy in Pre-Clinical Models of Acute Myeloid Leukemia

Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy

Spatiotemporal Mapping of Erythroid, Stromal, and Osteogenic Niche Formation to Support Physiologic Red Cell Production in a Three-Dimensional Hollow Fibre Perfusion Bioreactor

Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function

The IL-15 Super-Agonist ALT-803 Promotes Superior Activation and Cytotoxicity of Ex Vivo Expanded NK Cells Against AML

The Tumor Suppressors, MS4A3 and G0S2, Are Downregulated in CML Cells with BCR-ABL1 Kinase-Independent Resistance

BCR-ABL1 Molecular Remission After 90 y-Epratuzumab Tetraxetan Radioimmunotherapy In CD22 + Ph + B-ALL: A Potential New Treatment Paradigm

Dose Escalation of Azacitidine in Patients Failing Standard or Investigational Combinations of the Agent in the Myelodysplastiic Syndrome or Evolved AML

Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial.

IL-7 as a Membrane-Bound Molecule for the Costimulation of Tumor-Specific T Cells.

DNMT3b’s Role in Hematopoietic Stem Cell Self-Renewal.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only